JP2016536315A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536315A5
JP2016536315A5 JP2016527404A JP2016527404A JP2016536315A5 JP 2016536315 A5 JP2016536315 A5 JP 2016536315A5 JP 2016527404 A JP2016527404 A JP 2016527404A JP 2016527404 A JP2016527404 A JP 2016527404A JP 2016536315 A5 JP2016536315 A5 JP 2016536315A5
Authority
JP
Japan
Prior art keywords
tissue
tissue matrix
galactose
collagen
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016527404A
Other languages
English (en)
Japanese (ja)
Other versions
JP6524597B2 (ja
JP2016536315A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/063796 external-priority patent/WO2015066668A1/en
Publication of JP2016536315A publication Critical patent/JP2016536315A/ja
Publication of JP2016536315A5 publication Critical patent/JP2016536315A5/ja
Application granted granted Critical
Publication of JP6524597B2 publication Critical patent/JP6524597B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016527404A 2013-11-04 2014-11-04 α−ガラクトースを除去する方法 Expired - Fee Related JP6524597B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361899647P 2013-11-04 2013-11-04
US61/899,647 2013-11-04
PCT/US2014/063796 WO2015066668A1 (en) 2013-11-04 2014-11-04 Methods of removing alpha-galactose

Publications (3)

Publication Number Publication Date
JP2016536315A JP2016536315A (ja) 2016-11-24
JP2016536315A5 true JP2016536315A5 (enExample) 2017-12-28
JP6524597B2 JP6524597B2 (ja) 2019-06-05

Family

ID=51982769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016527404A Expired - Fee Related JP6524597B2 (ja) 2013-11-04 2014-11-04 α−ガラクトースを除去する方法

Country Status (10)

Country Link
US (2) US10307510B2 (enExample)
EP (2) EP3799893A1 (enExample)
JP (1) JP6524597B2 (enExample)
CN (1) CN105682697B (enExample)
AU (2) AU2014341866B2 (enExample)
BR (1) BR112016009178B1 (enExample)
CA (1) CA2925332C (enExample)
DK (1) DK3065790T3 (enExample)
ES (1) ES2846758T3 (enExample)
WO (1) WO2015066668A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3509541B1 (en) 2016-09-12 2021-09-01 Gebauer-Klopotek Patent Verwaltungs-UG (haftungsbeschränkt) Lenticules for intrastromal corneal implantation
CN106860861B (zh) * 2017-03-03 2020-11-03 北京博辉瑞进生物科技有限公司 一种免疫增强组合物、制备方法及其应用
US11633520B2 (en) 2017-03-06 2023-04-25 Tei Biosciences, Inc. Perforated tissue graft
US20200000965A1 (en) * 2018-07-02 2020-01-02 Gebauer-Klopotek Patent Verwaltungs-Ug Stabilization of collagen scaffolds
US12350144B2 (en) 2018-07-02 2025-07-08 Gebauer-Klopotek Patent Verw Altungs-Ug Stabilization of collagen scaffolds
WO2021034928A1 (en) * 2019-08-20 2021-02-25 Lifecell Corporation Method of manufacturing particulate tissue products
CN111632196A (zh) * 2020-06-01 2020-09-08 内蒙古自治区中医药研究所 一种去α-半乳糖基抗原脱细胞基质的制备方法
CN115591019A (zh) * 2021-06-28 2023-01-13 金佩奇生物科技(南京)有限公司(Cn) 脱细胞材料制备方法及其应用
CN115591020A (zh) * 2021-06-28 2023-01-13 金佩奇生物科技(南京)有限公司(Cn) 疝修复真皮补片材料的制备及应用
CN114276974A (zh) * 2021-12-24 2022-04-05 上海理工大学 封装细胞的间质材料及其制备方法和应用
CN114377206B (zh) 2021-12-24 2022-09-30 杭州华迈医疗科技有限公司 一种脱细胞基质生物材料的制备方法

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5230097A (en) 1975-09-02 1977-03-07 Kaneyasu Miyata Method of mounting different substitute blood vessel
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US5116615A (en) 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy
US6482404B1 (en) 1989-10-12 2002-11-19 David James White Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
RO109863B1 (ro) 1989-10-12 1995-06-30 Imutran Ltd Gena care codifica cel putin un factor de restrictie complementar, animal transgenic si metode de transplantare a tesuturilor sau organelor animale
US5846715A (en) 1990-05-11 1998-12-08 The Austin Research Institute CD46 variants
US8067149B2 (en) 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
US5374539A (en) 1991-06-17 1994-12-20 Nimni; Marcel E. Process for purifying collagen and generating bioprosthesis
WO1994021799A1 (en) 1993-03-16 1994-09-29 Austin Research Institute USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES
US6331658B1 (en) 1993-04-20 2001-12-18 Integris Baptist Medical Center, Inc. Genetically engineered mammals for use as organ donors
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
WO1995020661A1 (en) 1994-01-27 1995-08-03 Bresatec Ltd. Materials and methods for management of hyperacute rejection in human xenotransplantation
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
JPH10504442A (ja) 1994-04-13 1998-05-06 バイオトランスプラント,インコーポレイテッド α(1,3)ガラクトシルトランスフェラーゼ陰性ブタ
WO1995034202A1 (en) 1994-06-15 1995-12-21 Alexion Pharmaceuticals, Inc. Methods for reducing hyperacute rejection of xenografts
US5547681A (en) 1994-07-14 1996-08-20 Union Carbide Chemicals & Plastics Technology Corporation Dermal patch
AUPM772494A0 (en) 1994-08-30 1994-09-22 Austin Research Institute, The Improvements in production of proteins in host cells
AU5564996A (en) 1995-04-19 1996-11-07 St. Jude Medical Inc. Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5782915A (en) 1995-09-15 1998-07-21 Stone; Kevin R. Articular cartilage heterografts
US6166288A (en) 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
CA2233705A1 (en) 1996-08-02 1998-02-12 The Austin Research Institute Improved nucleic acids encoding a chimeric glycosyltransferase
US6455037B1 (en) 1996-11-01 2002-09-24 Mount Sinai School Of Medicine Of The City University Of New York Cells expressing an αgala nucleic acid and methods of xenotransplantation
DE69730039T2 (de) 1996-11-05 2005-07-14 Purdue Research Foundation, West Lafayette Herztransplantate
US6099567A (en) 1996-12-10 2000-08-08 Purdue Research Foundation Stomach submucosa derived tissue graft
JP4638562B2 (ja) 1996-12-10 2011-02-23 パーデュー・リサーチ・ファウンデーション 脊椎動物肝臓組織由来の生物材料
WO1998042850A1 (en) 1997-03-26 1998-10-01 Rpms Technology Limited Anticoagulant fusion protein anchored to cell membrane
ES2231980T3 (es) 1997-04-11 2005-05-16 Cryolife, Inc. Descelurizacion de un tejido.
JP2002507907A (ja) 1997-06-27 2002-03-12 バーダー、アウグスチヌス 生合成移植片及びその製造方法
US6613278B1 (en) 1998-11-13 2003-09-02 Regeneration Technologies, Inc. Tissue pooling process
US6482584B1 (en) 1998-11-13 2002-11-19 Regeneration Technologies, Inc. Cyclic implant perfusion cleaning and passivation process
US6652818B1 (en) 1998-11-13 2003-11-25 Regeneration Technologies, Inc. Implant sterilization apparatus
US6371992B1 (en) 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
AU759086B2 (en) 1998-03-06 2003-04-03 Crosscart, Inc. Soft tissue xenografts
US6383732B1 (en) 1999-02-11 2002-05-07 Crosscart, Inc. Method of preparing xenograft heart valves
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
GB9809280D0 (en) 1998-04-30 1998-07-01 Rpms Technology Ltd Immunosupression
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
EP1082006B1 (en) 1998-05-26 2006-02-01 Lifecell Corporation Cryopreservation of human red blood cells
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
WO1999065470A1 (en) 1998-06-19 1999-12-23 Lifecell Corporation Particulate acellular tissue matrix
US6743574B1 (en) 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6734018B2 (en) 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
GB2345638A (en) 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US20020110609A1 (en) 1998-12-28 2002-08-15 David Hung Increasing retrievable fluid from a breast duct
NZ550899A (en) 1999-01-13 2008-07-31 Revivicor Inc Double nuclear transfer method and the production of a non human animal thereby
US6267786B1 (en) * 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
US20030068815A1 (en) 1999-02-11 2003-04-10 Stone Kevin R. Sterilized xenograft tissue
US20020012660A1 (en) 1999-03-04 2002-01-31 Alan Colman Method of preparing a somatic cells for nuclear transfer
CN1266716A (zh) 1999-03-12 2000-09-20 中国人民解放军第四军医大学第一附属医院 交联型猪脱细胞真皮片
US6381026B1 (en) 1999-03-15 2002-04-30 Lifecell Corp. Method of measuring the contour of a biological surface
US8232320B2 (en) 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
CA2426669A1 (en) 1999-10-22 2001-05-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education .alpha.1-3 galactosyltransferase gene and promoter
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
US6866686B2 (en) 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
WO2001078798A1 (en) 2000-02-10 2001-10-25 Regeneration Technologies, Inc. Assembled implant
US20070009586A1 (en) 2000-02-29 2007-01-11 Cohen Kelman I Wound dressings containing complexes of transition metals and alginate for elastase sequestering
AU2001261650A1 (en) 2000-05-15 2001-11-26 Geron Corporation Ovine tissue for xenotransplantation
WO2002014480A2 (en) 2000-08-16 2002-02-21 Duke University Decellularized tissue engineered constructs and tissues
WO2002017936A1 (en) 2000-08-28 2002-03-07 Collagenesis, Inc. Methods for processing animal tissues
US20020077697A1 (en) 2000-12-15 2002-06-20 Ranieri John Paul Processed ratite carotid arteries as xenogeneic small bore vascular grafts
EP1373498A2 (en) 2001-03-21 2004-01-02 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
US7126039B2 (en) 2001-03-21 2006-10-24 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
US6933103B1 (en) 2001-03-21 2005-08-23 Brennen Medical, Inc. Biocompatible tissue for therapeutic use and method of making same
EP1383889B1 (en) 2001-04-30 2014-11-19 RBC Biotechnology, Inc. Modified organs and cells for xenotransplantation
JP2004529711A (ja) 2001-05-07 2004-09-30 クロスカート インコーポレイテッド 粘膜下異種移植片
WO2002092791A1 (en) 2001-05-14 2002-11-21 Stell Tissues or organs for use in xenotransplantation
GB2375771A (en) 2001-05-24 2002-11-27 Univ Leeds Decellularisation of tissue implant material
CA2452033C (en) 2001-06-28 2011-11-08 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
TWI284665B (en) 2001-08-17 2007-08-01 Univ Nat Cheng Kung Fabrication method of the porous collagen matrix
CA2462139A1 (en) 2001-09-27 2003-04-03 Timothy Albert Holton Stem-loop vector system
ES2672815T3 (es) 2001-10-18 2018-06-18 Lifecell Corporation Remodelación de tejidos y órganos
WO2003055302A1 (en) 2001-12-21 2003-07-10 The Curators Of The University Of Missouri Knockout swine and methods for making the same
JP4153878B2 (ja) 2001-12-29 2008-09-24 ソウル ナショナル ユニバーシティー インダストリー ファウンデーション Gt遺伝子が除去された複製豚及びその生産方法
JP2006507214A (ja) 2002-02-22 2006-03-02 イントラセル・リソーシーズ・エル・エル・シー 無菌の、免疫原性の、非腫瘍形成性の腫瘍細胞組成物及び方法
BR0304221A (pt) 2002-04-05 2004-07-27 Novozymes North America Inc Método para melhorar a resistência a abrasão e/ou força de tração de um material celulósico acabado em prensa durável, composição para tratar materiais celulósicos
JP2005524426A (ja) 2002-05-02 2005-08-18 パーデュー・リサーチ・ファウンデーション 血管新生が促進された移植片構成物
AUPS242702A0 (en) 2002-05-21 2002-06-13 Colltech Australia Limited Improved method for the extraction and purification of collagen
US6835385B2 (en) 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
EP1517715A2 (en) 2002-06-28 2005-03-30 Cardio, Inc. Decellularized tissue
AU2003265415A1 (en) 2002-08-14 2004-03-03 Immerge Biotherapeutics, Inc. Alpha(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND Alpha(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
PT1534819E (pt) 2002-08-21 2010-03-11 Revivicor Inc Animais porcinos carecendo de qualquer expressão de alfa 1,3-galactosiltransferase funcional
US20040037735A1 (en) 2002-08-23 2004-02-26 Depaula Carl Alexander Allograft tissue purification process for cleaning bone
WO2004020470A1 (ja) 2002-08-28 2004-03-11 Tissue Engineering Initiative Co., Ltd. システインプロテアーゼ処理コラーゲンの製造方法およびシステインプロテアーゼ処理コラーゲン
JP3658385B2 (ja) 2002-09-20 2005-06-08 佳宏 高見 皮膚の無細胞化方法、該方法による無細胞化真皮マトリックス及びその製造方法並びに該マトリックスを用いた複合培養皮膚
US7402319B2 (en) 2002-09-27 2008-07-22 Board Of Regents, The University Of Texas System Cell-free tissue replacement for tissue engineering
US7064187B2 (en) 2002-11-26 2006-06-20 Crosscart, Inc. Substantially non-immunogenic injectable collagen
US20040187877A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
US20040191226A1 (en) 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of body wall
DE60335602D1 (de) 2002-12-18 2011-02-17 Roche Diagnostics Gmbh Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
US20040176855A1 (en) 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
US20040175366A1 (en) 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US7067298B2 (en) 2003-03-31 2006-06-27 Ambion, Inc. Compositions and methods of using a synthetic Dnase I
JP2007525955A (ja) 2003-06-06 2007-09-13 ユニバーシティー オブ ピッツバーグ ブタcmp−n−アセチルノイラミン酸ヒドロキシラーゼ遺伝子
US20050013870A1 (en) 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
AU2004259019B2 (en) 2003-07-21 2010-09-23 Lifecell Corporation Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue
AU2004290006A1 (en) 2003-11-05 2005-05-26 University Of Pittsburgh Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
WO2005081714A2 (en) 2003-11-21 2005-09-09 Revivicor, Inc. Use of interfering rna in the production of transgenic animals
US20050186286A1 (en) 2004-02-25 2005-08-25 Yoshihiro Takami Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix
EP1734814B1 (en) 2004-03-17 2015-01-21 Revivicor, Inc. Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
US7732180B2 (en) 2004-05-07 2010-06-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Porcine Forssman synthetase protein, cDNA, genomic organization, and regulatory region
US20050266390A1 (en) 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
US20060073592A1 (en) 2004-10-06 2006-04-06 Wendell Sun Methods of storing tissue matrices
WO2006074373A2 (en) 2005-01-06 2006-07-13 Crosscart, Inc. Immunochemically modified and sterilized xenografts and allografts
US9216236B2 (en) 2005-03-07 2015-12-22 Technion Research & Development Foundation Limited Natural tissue-derived decellularized matrix and methods of generating and using same
US20100112543A1 (en) 2005-03-16 2010-05-06 Manh-Dan Ngo Processing soft tissue, methods and compositions related thereto
EP1858319A2 (en) 2005-03-16 2007-11-28 Musculoskeletal Transplant Foundation Soft tissue processing
AU2006282783B2 (en) 2005-08-26 2013-06-06 Miromatrix Medical Inc. Decellularization and recellularization of organs and tissues
JP5002805B2 (ja) 2005-10-14 2012-08-15 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
JP5050197B2 (ja) 2006-07-31 2012-10-17 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
NZ597223A (en) 2006-10-06 2013-09-27 Anthrogenesis Corp Native (telopeptide) placental collagen compositions
ES2372116T3 (es) 2006-11-16 2012-01-16 The University Of Leeds Preparación de tejido para implantación meniscal.
WO2008125850A2 (en) 2007-04-16 2008-10-23 Tissue Science Laboratories Plc Methods and compositions for tissue regeneration
CA2684012A1 (en) 2007-04-16 2008-10-23 Tissue Science Laboratories Plc Vascular implant
WO2008146956A1 (en) 2007-05-06 2008-12-04 Byoung-Hyun Min Therapeutic composite for cartilage disorder using extracellular matrix (ecm) scaffold
US20080306610A1 (en) 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US20100296969A1 (en) 2007-06-12 2010-11-25 Musculoskeletal Transplant Foundation Process for sterilizing acellular soft tissue under vacuum
US20100291532A1 (en) 2007-06-12 2010-11-18 Musculoskeletal Transplant Foundation Process for sterilizing acellular soft tissue with irradiation
ES2840251T3 (es) 2007-07-10 2021-07-06 Lifecell Corp Composiciones acelulares de matriz tisular para reparación de tejidos
CZ301086B6 (cs) 2007-10-17 2009-11-04 Bio-Skin, A. S. Sterilní autologní, allogenní nebo xenogenní implantát a zpusob jeho výroby
TWI353845B (en) 2008-03-19 2011-12-11 Food Industry Res & Dev Inst Process for preparing peptide products for promoti
GB0807868D0 (en) 2008-04-30 2008-06-04 Knight David P Cartilage repair material and a method for the preparation thereof
ES2755178T3 (es) 2008-06-06 2020-04-21 Lifecell Corp Tratamiento de elastasa de matrices tisulares
CA2752899A1 (en) 2009-02-18 2010-08-26 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US9155323B2 (en) 2009-05-15 2015-10-13 Siebte Pmi Verwaltungs Gmbh Aqueous process for preparing protein isolate and hydrolyzed protein from an oilseed
US8198408B2 (en) 2009-07-27 2012-06-12 National Cheng Kung University Method for preparing porous collagen matrices
US9888999B2 (en) 2009-08-11 2018-02-13 Aziyo Biologics, Inc. Acellular dermal allografts and method of preparation
ES2719816T3 (es) 2010-02-26 2019-07-16 Decell Tech Inc Métodos para la descelularización de tejidos
GB2482166A (en) 2010-07-22 2012-01-25 Tissue Science Lablratories Ltd Manufacture of collagenous material from use in therapy from collagen particles
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
ES2847409T3 (es) * 2011-04-28 2021-08-03 Lifecell Corp Método para el tratamiento enzimático de productos de tejidos
US20130122583A1 (en) 2011-11-10 2013-05-16 Celxcel Pty Ltd Sterilization process
ES2716993T3 (es) * 2012-03-08 2019-06-18 Lifecell Corp Matrices de colágeno y tejido activadas por enzimas

Similar Documents

Publication Publication Date Title
JP2016536315A5 (enExample)
ATE500319T1 (de) Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
ATE524070T1 (de) Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
Wang et al. Decellularized tendon as a prospective scaffold for tendon repair
EP4364799A3 (en) Mesenchymal stem cell-derived extracellular vesicles and their medical use
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
CN105682697B (zh) 去除α-半乳糖的方法
JP2015509360A5 (enExample)
JP2016520068A5 (enExample)
ATE528025T1 (de) Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung
MX2018006803A (es) Formulaciones moldeables que contienen un oxisterol en una matriz de tejido acelular.
RU2017139096A (ru) Композиция, содержащая биосовместимый матрикс, способ получения композиции
WO2008154621A3 (en) Process for sterilizing acellular soft tissue under pressure
Soffer-Tsur et al. Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues
WO2014053906A8 (en) The application of stem cells in the orthodontic maxillary expansion
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
WO2019132604A3 (ko) 인간 섬유연골 또는 탄성연골 재생용 조성물
RU2012104553A (ru) Клетки, производные от кардиальной ткани
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
EP4636078A3 (en) Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent
CN102580152A (zh) 一种制备脱细胞骨的方法
CN101946761B (zh) 制作动物剥制标本的处理液
EP4069267A4 (en) Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject
WO2020061067A8 (en) Compositions and methods for treating bone injury